Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion VerdictJohnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict
    Israeli medical imaging firm Nanox raises 26 million dollarsIsraeli medical imaging firm Nanox raises 26 million dollars
    Metropolis Healthcare signs binding agreement to buy Shraddha DiagnosticsMetropolis Healthcare signs binding agreement to buy Shraddha Diagnostics
    Novo Nordisks Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVDNovo Nordisk's Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and...
    Wockhardt gets DCGI nod for 2 new antibioticsWockhardt gets DCGI nod for 2 new antibiotics
    Group B Streptococcus: Hilleman Labs announces to make affordable vaccineGroup B Streptococcus: Hilleman Labs announces to make affordable vaccine
    Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFOEli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO
    FICCI raises concern on delay by govt in notifying E-pharmacy rulesFICCI raises concern on delay by govt in notifying E-pharmacy rules
    Govt may impose anti-dumping duty on pharma chemical from China, Saudi ArabiaGovt may impose anti-dumping duty on pharma chemical from China, Saudi Arabia
    Amgen DoorAmgen CEO expects 25% of growth to come from Asia in next decade
    No discussion on alleged bribes given by pharma firms to doctors at PM Modis meet, claims IPANo discussion on alleged bribes given by pharma firms to doctors at PM Modi's meet, claims IPA
    CapacitCapacit'e Infraprojects bags Rs 407 crore order in Mumbai
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok